INTRODUCTION {#S1}
============

Differential growth is the basis of all plant morphology and is determined by cell proliferation, cell expansion and the orientation of cell division. In the cambium and procambium, which are meristems from which vascular tissue is derived, cells divide down their long axis in a highly oriented manner, perpendicular to the radial axis of the stem. These divisions result in highly distinctive cell files that are characteristic of the xylem in most dicots. The cell files that are generated are also essential for maintaining the spatial separation of xylem and phloem ([@R5]). These properties make vascular tissue an ideal system for examining factors that regulate cell division and its effect on tissue organisation during differential growth.

CLE41 (CLAVATA3/ESR LIKE 41) and PXY (PHLOEM INTERCALATED WITH XYLEM) are a ligand-receptor pair, constituting a multifunctional pathway that regulates vascular cell division, vascular bundle organisation and xylem differentiation ([@R8]; [@R11]; [@R18]). Vascular bundle organisation defects in *pxy* mutants are characterised by intercalation of xylem and phloem, which is in contrast to the wild type where they are spatially separated. Defects in organisation are apparent even in the early stages of *pxy* vascular tissue differentiation ([@R11]).

PXY ligand, CLE41, is expressed in the phloem ([@R8]; [@R18]) and therefore ideally placed to confer positional information to PXY that is expressed in the adjacent vascular procambium ([@R11]). Ectopic overexpression of *CLE41* using constitutive or xylem-specific promoters results in both increased vascular cell division, and organisational defects in the vascular tissue. This is consistent with a role for localised CLE41 expression providing a positional signal to PXY that is required for correct orientation of the division plane in vascular stem cells ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S1A,B) ([@R8]).

Although these experiments are all consistent with a role for *PXY* and *CLE41* in regulating the orientation of vascular cell division, an alternative model for the intercalation of xylem and phloem in *pxy* mutants ([@R19]) followed the identification of a downstream target of CLE41/PXY signalling as *WOX4. WOX4* had previously been shown to promote vascular cell division ([@R23]), and its expression was found to be rapidly increased by exogenous application of TDIF ([@R19]), the active peptide derived from *CLE41, CLE42* and *CLE44* ([@R21]). *wox4 pxy* mutants were reported with a phenotype stronger than that of *pxy* single mutants and consequently, an 'enhanced cavity' model was put forward whereby adjacent xylem vessels and phloem were proposed to be the result of differentiation of cells in the vascular meristem, resulting in loss of spatial separation of xylem and phloem ([@R19]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S1C). Because TDIF has been shown to repress xylem differentiation in cell culture, and plants overexpressing both *CLE41* and *PXY* result in more undifferentiated vascular cells ([@R8]; [@R18]; [@R21]), it was suggested that the 'cavity' is the result of the meristem differentiating into xylem and that vascular cell proliferation subsequently reinitiates via a compensatory mechanism between the phloem and cortex ([@R19]). A compensatory mechanism has recently been described that involves ethylene maintaining vascular cell numbers by promoting vascular cell division in the absence of functional *pxy* or *wox4* ([@R9]).

Although *WOX4* is reported to be downstream of *pxy*, no reduction in *WOX4* expression has been reported in *pxy* mutant seedling hypocotyls, demonstrating that the *pxy* phenotype is not a result of changes in *WOX4* expression ([@R19]). Alternative transcriptional targets of PXY/CLE41 signalling must therefore exist.

*ERECTA* (*ER*) encodes a *RLK* involved in mediating cell-cell communication in several plant developmental contexts ([@R41]), including repression of xylem expansion in hypocotyls ([@R31]). The importance of the role of *ER* in cell-cell communication is perhaps most clearly evident in stomatal spacing, which *ER* controls together with the related *RLK* proteins *ERECTA-LIKE1* (*ERL1*) and *ERL2* ([@R37]), collectively referred to as the *ER* family (*ERf*), and with members of the *EPIDERMAL PATTERNING FACTOR LIKE* (*EPFL*) family that encode ligands for ERf receptors ([@R15]; [@R16]; [@R20]; [@R27]). In the cortex, *ERf* receptors also have a role in promoting cell division ([@R36]), controlled by *CHALLAH* (*CHAL*), *CHALLAH-LIKE1* (*CLL1*) and *CLL2* ligands (*EPFL6, EPFL*5 and *EPFL4*, respectively). *CHAL* and *CLL2* are expressed in the endodermis and signal to ER, which is present in the phloem, promoting growth of the inflorescence stem ([@R1]; [@R40]).

Here, we demonstrate that *WOX14* acts redundantly with *WOX4* in promoting vascular cell division downstream of PXY signalling. *wox4 wox14* double mutants demonstrate similar reductions in vascular cell division to those observed in *pxy wox4* lines, but do not have vascular organisation defects. By contrast, *er* dramatically enhances the effects of *pxy* on organisation of inflorescence stem vascular bundles, resulting in intercalation of xylem and phloem, but *er* has no effect on vascular cell number. Our results suggest that vascular organisation can be disrupted in the absence of reductions in vascular cell division, and disrupted rates of cell division do not lead to disrupted vascular organisation.

MATERIALS AND METHODS {#S2}
=====================

Generation of plant stocks {#S3}
--------------------------

*wox14-1* and *er-124* T-DNA insertion mutants were identified using the TAIR database ([@R39]) and confirmed by PCR with primers described in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Table S1. *pxy-1, pxy-3, pxy-5, pxy-3 pxl1-2 pxl2-1, wox4-1, er-105 erl1-2 erl2-1, IRX3::CLE41* and *35S::CLE41* lines have been described previously ([@R8]; [@R11]; [@R36]). *IRX3::CLE41 wox4-1, pxy-5 er-124, pxy-3 wox4-1, wox14-1 wox4-1, pxy-3 wox14-1* and *pxy-3 wox4-1 wox14-1* were identified using standard PCR-based screening of segregating F2 populations using primers described in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Table S1. For *WOX14::GUS* lines, 2.5 kb of the *WOX14* upstream region was PCR amplified using primers described in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Table S1, and cloned into pKGWFS7 via pENTR-D-TOPO. Transgenic plants were generated using Agrobacterium infiltration ([@R7]). Images shown are representative of eight independent transgenic lines.

TDIF/P9A synthetic peptide treatments {#S4}
-------------------------------------

Seeds were plated on 0.5×MS, 1% Agar and stratified for 4 days at 4°C prior to transfer to a Sanyo MLR-351H plant growth chamber set at 23°C with constant light. After 5 days, seedlings were transferred to 0.5×MS liquid media supplemented with either 5 mM TDIF (His-Glu-Val-Hyp-Ser-Gly-Hyp-Asn-Pro-Ile-Ser-Asn) or negative control P9A (His-Glu-Val-Hyp-Ser-Gly-Hyp-Asn-Ala-Ile-Ser-Asn; Bachem, Switzerland) and maintained on a rocking platform for either 1 or 16 hours. Following treatment, samples were snap frozen and RNA was extracted using Trizol (Life Technologies, USA). RNA was DNase treated prior to cDNA synthesis using BioScript reverse transcriptase (Bioline, UK).

Gene expression analysis {#S5}
------------------------

qRT-PCR primary inflorescence stem expression analysis, was performed on stems from 5-week old plants (∼10 cm), stripped of side branches and cauline leaves and divided into three equal lengths. In all qRT-PCR analysis, cDNA was prepared as described above. qRT-PCR was carried out using SensiMix SYBR Hi-ROX reaction mix (Bioline), primers described in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Table S1, and an ABI Prism 7000 machine (Life Technologies) with the standard SYBR green detection programme. Melting curves were analysed to ensure single products were formed. Relative expression was determined using a version of the comparative threshold cycle (Ct) method using average amplification efficiency for each primer pair, determined using LinReg ([@R17]). Samples were normalised to *18S rRNA* (not shown) and *ACT2* (shown). Results were similar independent of the control used. Samples were measured in technical triplicates on biological triplicates.

For determination of spatial gene expression patterns in *WOX14::GUS* lines, stain was prepared as described previously ([@R44]). Plant tissue was stained overnight and destained in 70% ethanol. Methods for *in situ* hybridization using digoxigenin-labelled probes were carried out as described by Etchells et al. (Etchells et al., 2010). *WOX4* antisense probe was generated from a pT48 template ([@R38]). *WOX14* sense and antisense probes were made by cloning a *WOX14* PCR fragment, amplified using primers shown in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Table S1 into pGEM-T easy (Promega, USA), which was subsequently used in PCR with M13 primers to generate a probe template.

Histology {#S6}
---------

For thin sections, hypocotyls or tissue 1 cm from the base of inflorescence stems was fixed in FAA and dehydrated through an ethanol series prior to infiltration and subsequent embedding with JB4 embedding media. Sections (4 μm) were stained with 0.05% aqueous Toluidine Blue. Callose sieve plates marking the phloem were observed by staining hand sections with 500 mM Aniline Blue in 100 mM phosphate buffer (pH 7.2) and visualising tissue on a Leica DMR microscope using the UV lamp. Vascular tissue was considered to be ordered in vascular bundles when xylem and phloem could be separated by a simple arced line and in hypocotyls if xylem could be incorporated in an elliptical shape that excluded the phloem.

RESULTS {#S7}
=======

Evidence for factors downstream of PXY signalling in addition to *WOX4* {#S8}
-----------------------------------------------------------------------

*WOX4*, a downstream target of PXY signalling, is upregulated by application of CLE ligand in seedling hypocotyls; however, no reduction in *WOX4* expression was observed in *pxy* mutants ([@R19]). Consequently, *pxy* phenotypes cannot solely be attributable to changes in *WOX4* expression and we examined this possibility by crossing *IRX3::CLE41* and *wox4*, and comparing *IRX3::CLE41 wox4* with parental lines and wild-type counterparts. We reasoned that if other factors do act redundantly with *WOX4* then *wox4* mutants should only partially suppress a *CLE41* overexpression phenotype.

*wox4* mutants have been described with gross morphology that is similar to wild type but have been reported to contain fewer cells in vasculature undergoing secondary growth, either directly above the rosette leaves in inflorescence stems ([@R38]) or in seedling hypocotyls ([@R19]). We measured vascular cell division in areas of primary growth in 6-week-old plants 1 cm above the rosette, avoiding the secondary growth region directly above rosette leaves. At this developmental stage, *wox4* mutants demonstrated vascular cell numbers that were not significantly different from wild-type counterparts ([Fig. 1A](#F1){ref-type="fig"}). *IRX3::CLE41* plants are characterised with large vascular bundles containing many undifferentiated cells and also have phloem intercalated with xylem ([Fig. 1A](#F1){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S2A,B) ([@R8]). Analysis of vascular tissue in the stem revealed a significant modification of the *IRX3::CLE41* phenotype by *wox4*, as *wox4 IRX3::CLE41* vascular tissue demonstrated a 28.6% reduction in cell number when compared with *IRX3::CLE41*. However, *wox4* did not completely abolish the increase in cell division in *IRX3::CLE41* vascular tissue. *wox4 IRX3::CLE41* lines still had a further 28.6% more cells than wild type and 53.3% more than *wox4* single mutants ([Fig. 1A](#F1){ref-type="fig"}), clearly demonstrating that factors exist that act redundantly with *WOX4*, downstream of PXY signalling.

![***wox4* only partially suppresses the *CLE41* overexpression phenotypes.** (**A**) Mean number of cells per vascular bundle 1 cm from the base of inflorescence stems of 6-week-old wild type (Col). (**B**) Hypocotyl diameter of 6-week-old wild type, *IRX3::CLE41, wox4* and *wox4 IRX3::CLE41* plants. *P* values were determined using ANOVA with an LSD post-hoc test. Error bars indicate s.e.m.](DEV091314F1){#F1}

We tested whether evidence for *WOX4*-independent PXY targets was also present in hypocotyls, where vascular tissue undergoes secondary growth. *wox4 IRX3::CLE41* hypocotyls were 19.8% smaller than those of *IRX3::CLE41* lines, but as was the case in vascular bundles, *IRX3::CLE41 wox4* were larger than those observed in *wox4* single mutants ([Fig. 1B](#F1){ref-type="fig"}; [Fig. 2](#F2){ref-type="fig"}), demonstrating that *WOX4* acts with additional factors. Our previous analysis suggested that increases in vascular cell division associated with *CLE41* overexpression is entirely dependent on the presence of a PXY receptor as *pxy 35S::CLE41* lines are identical to *pxy* single mutants in *Arabidopsis* hypocotyls ([@R8]). As *wox4* acts as only a partial suppressor of *IRX3::CLE41*, we hypothesised that *WOX4* may act with other factors in mediating the promotion of cell division in the procambium in response to and downstream of PXY signalling.

![**Hypocotyl phenotype of *wox4 IRX3::CLE41* lines.** (A-D) Vascular tissue from 6-week-old hypocotyls. Upper and middle panels show Toluidine Blue-stained thin sections. Upper section is transverse, middle section is longitudinal. Lower panels are Analine Blue-stained hand sections viewed under a UV light. (**A**) Col wild-type vascular tissue with phloem (ph), cambium (c) and xylem (x) marked. (**B**) *IRX3::CLE41* plants with intercalated xylem and phloem. (**C**) *wox4* plants are organised similarly to wild type. (**D**) *wox4 IRX3::CLE41* lines, organised similarly to *IRX3::CLE41* but with smaller spaces between differentiated xylem and phloem. Scale bars: 50 μm (top and middle); 100 μm (bottom).](DEV091314F2){#F2}

Both *WOX4* and *WOX14* act downstream of PXY signalling {#S9}
--------------------------------------------------------

Our genetic analysis (Figs [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S2) suggested that *WOX4* is only partially responsible for promoting cell division downstream of the PXY signalling so must act redundantly with other factor(s). The CLE-RLK-WOX interaction in regulation of stem cell niches has been widely reported ([@R3]; [@R19]; [@R33]; [@R35]) so we analysed microarray data comparing expression in *pxy-3* mutants and wild type (experiment E-MEXP-2639, <http://www.ebi.ac.uk/arrayexpress>) ([@R9]), for changes in *WOX* expression. *WOX14* demonstrated a 1.7-fold reduction in expression in *pxy* suggesting that it may be regulated by PXY signalling. *WOX14* expression was compared with that of *WOX4*, a previously identified target of PXY signalling ([@R19]) in 5-day-old wild-type seedlings subjected to a 1- or 16-hour exposure to exogenous application of TDIF, the peptide derived from *CLE41* or negative control peptide P9A ([@R21]). Consistent with the observations of Hirakawa et al. ([@R19]), *WOX4* expression was increased following either a 1- or 16-hour treatment ([Fig. 3](#F3){ref-type="fig"}). Although *WOX14* expression appeared increased at 1 hour, differences in expression proved not significant ([Fig. 3A](#F3){ref-type="fig"}); however, at 16 hours a small (1.6-fold) but significant increase in expression was observed ([Fig. 3B](#F3){ref-type="fig"}) that occurred in a *PXY*-dependent manner, demonstrating that *WOX14* acts downstream of PXY signalling. Increases in *WOX14* expression were not dependent on functional *WOX4*, as a clear *WOX14* response to TDIF was observed in *wox4* mutant lines ([Fig. 3](#F3){ref-type="fig"}), demonstrating that *WOX14* is not a downstream target of *WOX4*.

![**Comparison of *WOX4* and *WOX14* expression in response to a TDIF stimulus.** (**A**) qRT-PCR showing *WOX4* (grey) and *WOX14* (black) expression changes in 5-day-old seedlings exposed to a 5 μM TDIF or P9A mock treatment for 1 hour, normalised to *ACT2*. (**B**) A similar experiment to A, except that plants were treated for 16 hours with TDIF or P9A. Samples were measured in technical triplicates on biological triplicates. *P* values were determined using ANOVA with an LSD post-hoc test. Error bars indicate s.e.m.](DEV091314F3){#F3}

Inflorescence stems represent a developmental series with most recently derived vascular tissue present in apical regions of the stem and the oldest tissue in basal regions. We compared *WOX4* and *WOX14* expression in apical, central and basal regions of inflorescence stems from 5-week-old plants using qRT-PCR and found that the dynamics of *WOX14* expression differed from that of *WOX4. WOX4* was expressed at a relatively consistent level along the length of the inflorescence stem ([Fig. 4A](#F4){ref-type="fig"}); however, *WOX14* expression was low at the top but expression increased along the apical-basal axis such that expression was 20-fold higher at the base than at the top ([Fig. 4B](#F4){ref-type="fig"}).

![***WOX4* and *WOX14* expression in inflorescence stems.** (**A**) qRT-PCR showing *WOX4* inflorescence expression in 5-week-old Col, *pxy* or *35S::CLE41* plants normalised to *ACT2*. (**B**) *WOX14* inflorescence expression in 5-week-old plants normalised to *ACT2. P* values were determined using ANOVA with an LSD post-hoc test; ^\*^*P*\<0.05; ^\*\*^*P*≤0.01. Error bars indicate s.e.m.](DEV091314F4){#F4}

*WOX4* and *WOX14* expression levels were also compared in *pxy* and *35S::CLE41* lines. *WOX4* expression was maintained at the level of wild-type expression in apical regions of *pxy* inflorescence stems; however, in central and basal regions *WOX4* expression was significantly reduced ([Fig. 4A](#F4){ref-type="fig"}). Consequently, we have demonstrated that PXY signalling is required for normal levels of *WOX4* expression. *WOX14* expression was also dependent upon *PXY* as mRNA levels were similarly reduced in *pxy* mutant stems ([Fig. 4B](#F4){ref-type="fig"}). In the apical third of the stem, *WOX14* expression was reduced in *pxy* by a small (1.3-fold) but significant amount, and this reduction was more apparent in the middle of the stem ([Fig. 4B](#F4){ref-type="fig"}). The trend of reduced *WOX14* expression appeared similar in the stem base of *pxy* mutants, but these differences proved not to be statistically significant.

In *35S::CLE41* lines, *WOX4* expression was increased approximately twofold at all stages of stem development relative to wild type ([Fig. 4A](#F4){ref-type="fig"}). *WOX14* expression levels were also elevated in these lines, but in this case the largest increase in expression was observed at the base of the stem ([Fig. 4B](#F4){ref-type="fig"}). Wild-type expression levels of *WOX4* and *WOX14* are therefore dependent on the presence of a PXY receptor kinase and promoted by PXY ligand, demonstrating that both of these WOX genes act downstream of PXY signalling.

*WOX14* is expressed predominantly in vascular tissue {#S10}
-----------------------------------------------------

We determined the spatial expression pattern of *WOX14* by generating eight independent *WOX14::GUS* lines. A 2.5 kb region of *WOX14* upstream regulatory sequence was cloned behind a GUS-GFP cassette in a binary vector and subsequently transformed into *Arabidopsis*. When subjected to staining, in all cases 14-day-old seedlings demonstrated no expression in leaves, cotyledons or in the shoot apex. Staining was observed where the leaves met the stem ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3A, arrows, upper panel). Strong staining was observed in the vascular cylinder of the hypocotyl and root, and was also apparent in the root elongation zone but not the root tip ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3A). In plants 5 weeks post-germination (inflorescence stem at 10 cm), GUS staining did not occur at the very top of the stem but was present 2 cm below the apex ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3B) where staining was predominantly in vascular strands but also present, albeit at a much lower level, between the vascular strands (arrowhead). At the base of inflorescence stems, 1 cm above the rosette, GUS staining was more intense in vascular strands but, unlike in apical parts of the inflorescence stem, was absent between vascular strands ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3B). In rosette leaves of 5-week-old plants, GUS stain was not observed in expanding leaves (not shown) but was present in midveins ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3B, arrowheads) but no other leaf veins of fully expanded leaves ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3B; arrow in lower panel). These results suggest that *WOX14* upstream regulatory sequences do not restrict expression in initiating vascular tissue but do promote *WOX14* expression in established vasculature.

To better understand cell-type specific *WOX14* expression in stained GUS lines, transverse inflorescence stem sections were taken to determine spatial expression within the vascular tissue. At 2 cm below the shoot apex, GUS staining was expressed broadly in vascular tissue, present in xylem, phloem and procambium; however, in vascular tissue at the base of stems 1 cm above the rosette, staining was restricted to the procambium and adjacent areas of xylem and phloem ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3C). To confirm that the GUS pattern represented a true reflection of *WOX14* expression, RNA *in situ* hybridization was performed on tissue from the same stage in development. In these experiments, *WOX14* antisense probes broadly marked the vascular bundles in apical sections, but demonstrated predominantly procambium expression in basal sections ([Fig. 5A](#F5){ref-type="fig"}), in common with the GUS lines ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S3C). By contrast, signal was not observed above background levels using a *WOX14* sense control ([Fig. 5C](#F5){ref-type="fig"}). To compare *WOX4* and *WOX14* expression, we also carried out *in situ* hybridization using an antisense probe previously described for *WOX4* ([@R38]). *WOX4* expression was confined to the procambium in both apical and basal sections ([Fig. 5B](#F5){ref-type="fig"}). Consequently, expression of both of these genes overlaps in the procambium.

![***WOX14* expression in inflorescence stem vascular bundles.** (A-C) Expression in inflorescence stem vascular bundles from 5-week-old plants (∼10 cm inflorescence); panels on the left show sections 2 cm below the shoot apex; panels on the right show sections 1 cm above the rosette. (**A**,**B**) *In situ* hybridization using antisense *WOX14* (A) and *WOX4* (C) probes. In apical sections, *WOX14* expression was present throughout the vascular bundle (A, LHS; arrowheads) but prominent in the procambium (arrow). *WOX4* expression was restricted to the procambium (B, LHS; arrowheads). In basal sections, *WOX14* expression was particularly prominent in the procambium (A, RHS; arrowheads). *WOX4* expression was procambium specific (B, RHS; arrowheads). (**C**) *WOX14* sense controls did not label above background levels. Scale bars: 25 μm.](DEV091314F5){#F5}

*WOX14* acts redundantly with *WOX4* in regulation of vascular cell division {#S11}
----------------------------------------------------------------------------

Expression analysis suggested that *WOX14* acts downstream of the PXY receptor (Figs [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}). Consequently, we identified a *wox14* T-DNA insertion mutant (GabiKat_469C11), renamed it *wox14-1* and used it to test for a role for *WOX14* in *Arabidopsis* vascular tissue. These plants exhibited no obvious alteration in plant growth or morphology (not shown), and no alterations in vascular organisation or cell number were observed (Figs [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}). We reasoned that *WOX4* and *WOX14* may act redundantly, so generated *wox4 wox14* double mutants. *wox4 wox14* gross morphology was also indistinguishable from that of wild-type plants; however, when cell number was analysed in vascular bundles, fewer cells were present in *wox4 wox14* than wild type or single mutants (Figs [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}), demonstrating that *WOX4* and *WOX14* act redundantly in promoting vascular cell division.

![**The *wox4* phenotype is enhanced by *wox14***. (**A**) Mean number of cells per vascular bundle 1 cm from the base of inflorescence stems of 8-week-old wild-type (Col), *wox4, pxy, wox4 pxy, wox14* and *wox4 wox14* plants. (**B**) Hypocotyl diameter of 8-week-old plants. *P* values were determined using ANOVA with an LSD post-hoc test. Error bars are s.e.m.](DEV091314F6){#F6}

![***wox4 wox14* double mutants have no vascular organisation defects.** (**A**) Transverse Toluidine Blue-stained sections of vascular tissue from 8-week-old inflorescence stems. (**B**) Transverse hypocotyl sections. LHS are Toluidine Blue stained; RHS are Analine Blue stained. Arrowheads indicate intercalated xylem and phloem in *pxy* and *pxy wox4*. Scales bars: 50 μm.](DEV091314F7){#F7}

Strikingly, *wox4 wox14* double mutant vascular bundles were smaller than those observed in *pxy* single mutants, and were a similar size to those observed in *pxy wox4* lines ([Fig. 6A](#F6){ref-type="fig"}). In contrast to *pxy* and *pxy wox4* lines, which exhibit characteristic defects in vascular organisation, organisation of *wox4 wox14* vascular bundles was similar to the wild type ([Fig. 7](#F7){ref-type="fig"}). A similar situation was observed in hypocotyls, where cambium activity was assessed by measuring hypocotyl diameter. *wox4 wox14* mutants demonstrated a similar diameter to that observed in *pxy* ([Fig. 6B](#F6){ref-type="fig"}), but in contrast to *pxy* ([Fig. 7B](#F7){ref-type="fig"}; arrowheads) no defects in vascular organisation were observed.

We further characterised the relationship between *pxy* and *wox14* by analysing *pxy wox14* and *pxy wox4 wox14* mutant combinations. *pxy wox14* lines were identical to *pxy* single mutants for all parameters tested, i.e. for vascular proliferation measures (cell number in inflorescence stem vascular bundles and hypocotyl diameter; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S4, S5) and for vascular organisation phenotypes (Analine Blue stained sections; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S5). This result is in contrast to that observed between *pxy* and *wox4* as *pxy wox4* lines demonstrate an enhancement ([@R19]). Similarly, *pxy wox4 wox14* triple mutants were identical to *pxy wox4* lines ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S4, S5). These observations are consistent with *WOX14* acting in an epistatic manner to *PXY*, and suggest that the strong phenotype observed in *pxy wox4* may in part be due to the loss of control of *WOX14* in *pxy* mutants.

*pxy* interacts with *er* during vascular development {#S12}
-----------------------------------------------------

Our results with *wox4* and *wox14* suggested that the vascular organisation defect in *pxy* mutants may be genetically separable from proliferation defects. In our original description of *pxy*, the *pxy-1* allele in L*er* background demonstrated a stronger organisation defect than mutants in the Col background ([@R11]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S6). *pxy-1* has a premature stop codon in the kinase domain that is presumably essential for transmitting the CLE41/42 signal through PXY, but a variety of Col *pxy* alleles, including those that entirely lack the kinase domain do not exhibit similarly strong phenotypes ([@R11]).

We explored the reasons behind the difference in the strength of L*er* and Col *pxy* alleles to investigate further whether vascular organisation and proliferation are genetically separable. One prominent difference between L*er* and Col ecotypes is the presence of a mutant *er* gene in L*er. ER* acts redundantly with closely related RLK proteins *ERL1* and *ERL2* in promotion of cell division in *Arabidopsis* ([@R36]), including in the vascular tissue ([Fig. 8](#F8){ref-type="fig"}), but is also involved in intertissue communication between endodermis and the phloem, where both *ER* ([@R40]) and *CLE41* ([@R8]) are expressed. We hypothesised that the severity of the *pxy-1* L*er* allele could be due to a genetic interaction between *pxy* and *er*. To test this, we isolated a novel *er* allele in the Col background which harboured a T-DNA insertion in the LLR region of the gene (GabiKat_364C05) ([@R32]), renamed *er-124* following the allelic sequence described ([@R26]). *er-124* was indistinguishable from other *er* alleles - siliques were short, blunt and wider than those of wild type, and inflorescence stems were shorter ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S7, S8). *er* single mutants demonstrated no inflorescence stem vascular cell division defects ([Fig. 8A](#F8){ref-type="fig"}) or secondary growth defects, as *er* hypocotyls were the same size as wild type ([Fig. 8B](#F8){ref-type="fig"}). We nevertheless examined whether *ER* and *PXY* interacted by generating *pxy er* double mutants. These plants accumulated anthocyanin in cotyledons ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S7D) in a manner reminiscent of the *pxy-1* L*er* allele ([@R11]). *pxy er* mutants demonstrated a height defect but this was an additive phenotype as average plant height was a combination of the reductions observed in the single mutants ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S7, S8). Similarly, no interaction was found between *pxy* and *er* in silique length (*pxy* mutants have the same pod length as wild type, *er* mutants are shorter and *er pxy* double mutant pods are the same as those of *er* single mutants; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S8). Consequently, *pxy* is not a general enhancer of *er*.

![***pxy er* mutants demonstrate that vascular proliferation and organisation are genetically separable.** (**A**) Mean number of cells per vascular bundle 1 cm from the base of inflorescence stems of 8-week-old wild-type, *pxy, er, er pxy, pxy pxl1 pxl2* and *er erl1 erl2* plants. (**B**) Hypocotyl diameter of 8-week-old wild-type, *pxy, er, er pxy, pxy pxl1 pxl2* and *er erl1 erl2* plants. *P* values were determined using ANOVA with an LSD post-hoc test. ^\*^*P*\<0.05, significantly different from *pxy*. Error bars indicate s.e.m.](DEV091314F8){#F8}

We assayed the average number of cells in inflorescence stem vascular bundles and found that *pxy er* double mutants had similar numbers of vascular cells to *pxy* single mutants ([Fig. 8](#F8){ref-type="fig"}) and, therefore, *er* does not enhance the *pxy* vascular cell number defect in inflorescence stems. However, vascular organisation has been quantitatively characterised by determining the width:length (tangential:radial) ratio of vascular bundles as a measure of changes in organisation in vascular bundles ([@R11]). We applied this measure to examine *pxy wox4* mutants that have been reported to have more severe vascular bundle disruption than *pxy* single mutants. Although *pxy wox4* did appear to show a small enhancement of the *pxy* phenotype ([Fig. 9A](#F9){ref-type="fig"}), much more striking changes in the shape of vascular bundles were observed in *pxy er* double mutants, and this was much greater than that observed for either of the corresponding single mutants ([Fig. 9B](#F9){ref-type="fig"}; [Fig. 10A](#F10){ref-type="fig"}). The large increase in the tangential:radial ratio in *pxy er* ([Fig. 9B](#F9){ref-type="fig"}) was similar to that of the original *pxy-1* allele ([@R11]). Consequently, *pxy er* double mutants have the same number of cells as *pxy* single mutants, but the shape of the vascular bundle is altered. We further investigated vascular organisation in *pxy er* lines by observing Analine Blue-stained hand sections and found that xylem and phloem were clearly intercalated in *pxy er* to a greater extent than observed in *pxy* single mutants ([Fig. 10A-D](#F10){ref-type="fig"}).

![**The tangential:radial ratio of inflorescence stem vascular bundles.** (**A**) Wild-type (Col), *wox4, pxy, wox4 pxy, wox14* and *wox4 wox14* plants. (**B**) Wild-type, *pxy, er, er pxy, pxy pxl1 pxl2* and *er erl1 erl2* plants. Error bars indicate s.e.m.](DEV091314F9){#F9}

![**Xylem and phloem are intercalated in *pxy er* mutants.** (**A-E**) Toluidine Blue-stained thin sections (upper panels); Analine Blue-stained hand sections (lower panels) of Col (A), *pxy* (B), *er* (C), *pxy er* (D) and *er erl1 erl2* (E) 8-week-old inflorescence stem vascular tissue. Vascular organisation is perturbed in *pxy* and severely perturbed in *pxy er* lines (arrowheads show adjacent xylem and phloem, which are spatially separated in wild type). (**F-J**) Toluidine Blue (upper) and Analine Blue (lower) stained sections of Col (F), *pxy* (G), *er* (H), *pxy er* (I) and *er erl1 erl2* (J) hypocotyl vascular tissue. Arrowheads indicate intercalated xylem and phloem. Scale bars: 50 μm.](DEV091314F10){#F10}

Finally, we analysed the *pxy er* interaction during secondary growth in hypocotyls. In contrast to our observations in the inflorescence stem, *pxy er* lines has fewer vascular cell divisions than those of *pxy* and *er* single mutants, as determined by hypocotyl diameter measurements ([Fig. 8B](#F8){ref-type="fig"}), suggesting that *ER* and *PXY* may interact to promote cell division during secondary growth; however, interpretation of this phenotype is not straightforward as *ER* is known to repress xylem expansion in this context ([@R31]).

*ER* expression overlaps with that of *CLE41* ([@R8]; [@R40]) so we tested whether *er* mutants displayed differences in *CLE41, CLE42* or *CLE44* expression; however, none was observed ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S9). Thin sections were analysed for morphological differences between *er* and wild type in the phloem, but no clear differences were apparent ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S10). Similarly, vasculature of *er erl1 erl2* triple mutants was analysed and these were found to retain wild-type organisation (Figs [9](#F9){ref-type="fig"}, [10](#F10){ref-type="fig"}), despite large reductions in vascular cell number ([Fig. 8](#F8){ref-type="fig"}).

DISCUSSION {#S13}
==========

*WOX4* acts as a transcriptional target for PXY signalling controlling the rate of vascular cell division; however, vascular proliferation caused by overexpression of the PXY ligand in *IRX3::CLE41* lines was only partially abolished in *wox4 IRX3::CLE41* (Figs [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S2), suggesting that other factors must also act downstream of PXY to promote vascular cell divisions. PXY could act redundantly with other RLK proteins such that *WOX4* levels are partially maintained in *pxy* owing to CLE41 acting through redundant receptors and this model would be consistent with transmission of the CLV3 signal in the shoot apical meristem, which acts through the CLV1 receptor ([@R6]; [@R12]; [@R30]), RECEPTOR-LIKE PROTEIN KINASE2 ([@R24]) and CLV2-CORYNE receptor heterodimers ([@R22]; [@R29]; [@R46]). There is some support for this hypothesis, as levels of *WOX4* expression were partially increased upon a 16-hour TDIF induction in *pxy* mutants ([Fig. 3](#F3){ref-type="fig"}). However, although there is evidence of enhancement of the organisational defect in *pxy* by mutating related RLK genes *PXL1* and *PXL2* ([@R11]), there is no evidence of enhancement of the *pxy* cell division phenotype ([@R11]) ([Fig. 9](#F9){ref-type="fig"}), suggesting that if further receptors do confer the TDIF signal promoting cell division they are not closely related to *PXY*. On the other hand, in our previous analysis, we observed that hypocotyl diameter increases in *35S::CLE41* lines were suppressed in *35S::CLE41 pxy* apparently to the level of *pxy* mutants ([@R8]), so although this analysis does not completely rule out receptor redundancy in promoting cell division, it suggests that any redundancy is likely to be limited. As *WOX4* levels are unchanged in *pxy* mutant seedlings, despite a clear phenotype ([@R19]), we hypothesised that *WOX4*-redundant transcriptional targets of PXY signalling may be present. *WOX14* is related to *WOX4* ([@R14]), downregulated in *pxy* mutants and upregulated in lines overexpressing *CLE41* ([Fig. 4](#F4){ref-type="fig"}). Strikingly, when expression of *WOX4* and *WOX14* was compared in *pxy* mutants, *WOX4* was significantly reduced at the base of stems, in contrast to *WOX14*, the expression of which was reduced at the top of stems. These results suggest that PXY-mediated control of *WOX* expression is dependent on developmental stage ([Fig. 4](#F4){ref-type="fig"}).

*wox14* strongly enhanced *wox4*, such that *wox4 wox14* mutants had comparable cell division defects to those observed in *pxy wox4* double mutants (Figs [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}). However, *pxy wox14* plants were indistinguishable from *pxy* single mutants ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S4, S5). *pxy wox4 wox14* lines appeared identical to *pxy wox4* and had vascular cell numbers similar to those of *wox4 wox14* ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S4, S5). These observations are consistent with *WOX14* acting downstream of *PXY* and redundantly with *WOX4* ([Fig. 11](#F11){ref-type="fig"}). Strikingly, *wox4 wox14* double mutants exhibited no defect in the organisation of vascular tissue in contrast to that observed in *pxy, pxy wox14* and *pxy wox4* lines (Figs [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Figs S4, S5).

![**The interaction between *PXY*, *WOX4*, *WOX14* and *ER***. *PXY* and *ER* signalling modules interacting in the *Arabidopsis* stem. Procambium-expressed *PXY* controls cell division number via *WOX4* and *WOX14* as a separate outcome from vascular organisation. *ER*, which in stems is expressed in the epidermis, phloem and xylem, is required non-cell autonomously with *PXY* to control vascular organisation.](DEV091314F11){#F11}

Partly based upon the phenotype of *pxy wox4* mutants, it has been proposed that the organisation defect in *pxy* is due to consumption of the vascular meristem in some cell files followed by re-initiation of a vascular developmental programme (cavity model; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S1C) ([@R19]). At the shoot apex, *shoot meristemless* ([@R2]), *wuschel* ([@R25]) and *pinhead* ([@R28]) mutants all have defective apical meristems but in all instances, some level of meristem re-initiation occurs in adventitious positions on the flank of the original meristem. We have previously demonstrated that a mechanism exists whereby procambial cell divisions are promoted by ethylene in the absence of PXY signalling ([@R9]). *wox4 wox14* double mutants have a more severe proliferation defect to that observed in *pxy* mutants but vascular organisation is maintained; consequently, our results suggest that if the cavity model can explain the loss of vascular organisation in *pxy* it must involve factors other than *WOX4* and *WOX14*.

For the 'localised ligand' model to be correct, the rate of cell division and vascular organisation must be genetically separable, independent outputs of *pxy* signalling. Evidence that this is the case comes from analysis of *pxy er* double mutants. Vascular cell number in *pxy er* lines was unchanged compared with that observed in *pxy* single mutants; however, defects in the arrangement of vascular tissue along the tangential and radial axes were observed ([Fig. 8B](#F8){ref-type="fig"}) in addition to more prominent intercalation of xylem and phloem in *pxy er* compared with *pxy*. Our model, in which procambium-expressed PXY receives positional information from the phloem is analogous to a WNT signalling-controlled oriented cell division in *C. elegans* EMS cells ([@R13]; [@R34]). ER protein interacts directly with the TOO MANY MOUTHS (TMM) receptor controlling asymmetric cell divisions during stomata development ([@R1]; [@R27]); however, a distinct mechanism must work in the context of vascular tissue. *ER* is able to affect vascular organisation in the procambium but in stems it is expressed in the xylem, phloem and epidermis ([@R40]). As such, it does not overlap with procambium-expressed *PXY* ([@R8]), making a physical interaction between PXY and ER proteins unlikely. Although the PXY ligands CLE41/42/44 are also phloem expressed, their mRNA levels are unaffected in *er* mutants ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.091314/-/DC1) Fig. S9). Within the stem CHAL, CLL1 and CLL2 have been identified as the ligands for ER, yet they are expressed specifically in the endodermis ([@R1]; [@R40]). Neither *chal/cll* ([@R40]) nor *ERf* mutants (Figs [9](#F9){ref-type="fig"}, [10](#F10){ref-type="fig"}) exhibit defects in the orientation of vascular cell division. Although it may be the case that the change in vascular organisation in *pxy er* is due to an unknown effect caused by the pleiotropic nature of *er* loss-of-function phenotypes, we speculate that the interaction between *PXY* and *ER* may represent a novel signalling pathway that coordinates differential growth over several cell layers in *Arabidopsis* via non-cell autonomous factors acting downstream of *ER* ([Fig. 11](#F11){ref-type="fig"}).

In plants, there are a growing number of cell-surface receptors described as conferring positional information in proliferating cell lineages, possibly as a consequence of interpreting positional information derived from excreted peptide ligands. In the epidermis, stomatal spacing is enforced through EPF ligands signalling to TMM/ERf receptors ([@R1]; [@R15]; [@R27]) and similarly in anthers, the ligand TAPETUM DETERMINANT 1 ([@R42]) signals to the EXCESS MICROSPOROCYTES 1 receptor ([@R43]), resulting in oriented divisions that form the tapetum in a contiguous layer ([@R4]; [@R10]; [@R45]). We suggest that this may be a general mechanism for maintaining tissue integrity during cell division and differentiation during differential growth.
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